Take the short online assessment and find out in minutes
Current scientific evidence does not support ideas such as losing weight automatically or melting fat without effort
Persistent, patchy, or scarring hair loss is never "just" GLP-1-related shedding and always warrants an in-person evaluation to rule out alopecia areata, scalp psoriasis, or thyroid-related alopecia
employers heading into 2027, a trend driven by climbing overall costs that have persisted even as the per-unit price of individual medications has declined
high discontinuation rates (e.g., 5067 %% at one year and 85 % at two years [[5], [6], [7], [8]]) that may relate to side effects, costs, variable individual efficacy, or patient preferences [5,9]
We have 165 employees, but we have about 40 of them that are on GLP-1 agonists for weight loss